Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
DOI: | 10.33448/rsd-v10i11.19787 |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/19787 |
Resumo: | Introduction: The whole world is still experiencing a health emergency caused by the pandemic of the new SARS-Cov-2 coronavirus, recently, ivermectin, previously shown to have broad-spectrum antiviral activity in vitro, has been shown to be an inhibitor of the SARS-CoV-2 virus , in this scenario, the article aims to analyze the pharmaceutical performance in drugstores, and compare the pattern of consumption of the drug Ivermectin in the period of the Covid-19 pandemic in the city of Redenção-PA. Methods: An exploratory, retrospective descriptive study was carried out, with the methodological documental procedure in the evaluation of sales records of 05 (five) drugstores in the city of Redenção-PA on the indiscriminate use of ivermectin during the pandemic. The study was carried out by reviewing the sales reports issued in 3 (three) months, namely: March/April/May 2019/2020/2021, respectively. Results and discussion: During the study, a jump in the consumption of ivermectin was observed in 2020, due to the intense search for curative or preventive measures by Covid-19. On the other hand, we recorded a drop in sales of this medication in 2021, due to vaccination in Brazil and the performance of studies that highlight that in none of them the in vivo action of the medication was proven. Final Considerations: It is up to the pharmacist, the last link between the medication and the patient, to guide and prevent the indiscriminate use of ivermectin, since there is enough data to abandon the use of these medications, due to overwhelming evidence that they do not help in the treatment. |
id |
UNIFEI_a9770d1a9ef7044cda1c1dd3022a048c |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/19787 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
spelling |
Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative studyIntervención farmacéutica en el uso indiscriminado de ivermectina: un estudio comparativoIntervenção farmacêutica no uso indiscriminado da ivermectina: um estudo comparativoIvermectinaFarmacêuticoCovid-19.IvermectinaFarmacéuticaCovid-19.IvermectinPharmaceuticalCovid-19.Introduction: The whole world is still experiencing a health emergency caused by the pandemic of the new SARS-Cov-2 coronavirus, recently, ivermectin, previously shown to have broad-spectrum antiviral activity in vitro, has been shown to be an inhibitor of the SARS-CoV-2 virus , in this scenario, the article aims to analyze the pharmaceutical performance in drugstores, and compare the pattern of consumption of the drug Ivermectin in the period of the Covid-19 pandemic in the city of Redenção-PA. Methods: An exploratory, retrospective descriptive study was carried out, with the methodological documental procedure in the evaluation of sales records of 05 (five) drugstores in the city of Redenção-PA on the indiscriminate use of ivermectin during the pandemic. The study was carried out by reviewing the sales reports issued in 3 (three) months, namely: March/April/May 2019/2020/2021, respectively. Results and discussion: During the study, a jump in the consumption of ivermectin was observed in 2020, due to the intense search for curative or preventive measures by Covid-19. On the other hand, we recorded a drop in sales of this medication in 2021, due to vaccination in Brazil and the performance of studies that highlight that in none of them the in vivo action of the medication was proven. Final Considerations: It is up to the pharmacist, the last link between the medication and the patient, to guide and prevent the indiscriminate use of ivermectin, since there is enough data to abandon the use of these medications, due to overwhelming evidence that they do not help in the treatment.Introducción: El mundo entero sigue experimentando una emergencia sanitaria provocada por la pandemia del nuevo coronavirus SARS-Cov-2, recientemente se ha demostrado que la ivermectina, previamente demostrada con actividad antiviral de amplio espectro in vitro, es un inhibidor de la Virus SARS-CoV-2, en este escenario, el artículo tiene como objetivo analizar el desempeño farmacéutico en las farmacias, y comparar el patrón de consumo del fármaco Ivermectina en el período de la pandemia Covid-19 en la ciudad de Redenção-PA. Métodos: Se realizó un estudio exploratorio, descriptivo retrospectivo, con el procedimiento documental metodológico en la evaluación de registros de ventas de 05 (cinco) farmacias de la ciudad de Redenção-PA sobre el uso indiscriminado de ivermectina durante la pandemia. El estudio se llevó a cabo revisando los informes de ventas emitidos en 3 (tres) meses, a saber: marzo / abril / mayo 2019/2020/2021, respectivamente. Resultados y discusión: Durante el estudio se observó un salto en el consumo de ivermectina en 2020, debido a la intensa búsqueda de medidas curativas o preventivas por parte de Covid-19. Por otro lado, registramos una caída en las ventas de este medicamento en 2021, debido a la vacunación en Brasil y la realización de estudios que resaltan que en ninguno de ellos se comprobó la acción in vivo del medicamento. Consideraciones finales: Corresponde al farmacéutico, último vínculo entre el medicamento y el paciente, orientar y prevenir el uso indiscriminado de ivermectina, ya que existen datos suficientes para abandonar el uso de estos medicamentos, debido a la abrumadora evidencia de que lo hacen. no ayuda en el tratamiento.Introdução: O mundo inteiro ainda passa pela emergência sanitária provocada pela pandemia do novo coronavírus SARS-Cov-2, recentemente, a ivermectina, anteriormente demonstrada como tendo atividade antiviral de amplo espectro in vitro, demonstrou ser um inibidor do vírus SARS-CoV-2, nesse cenário o artigo tem como objetivo analisar a atuação farmacêutica em drogarias, e comparar o padrão de consumo do medicamento Ivermectina no período da pandemia de Covid-19 no município de Redenção-PA. Métodos: Foi realizado um estudo exploratório, descritivo retrospectivo, sendo o procedimento metodológico documental na avaliação dos registros de vendas de 05 (cinco) drogarias na cidade de Redenção-PA sobre o uso indiscriminado de ivermectina durante a pandemia. O estudo foi realizado através da revisão dos relatórios de vendas expedidos em 3 (três) meses, sendo estes: Março/Abril/Maio de 2019/2020/2021, respectivamente. Resultados e discussão: Foi observado durante o estudo um salto no consumo de ivermectina no ano de 2020, devida intensa procura por medidas curativas ou preventivas da Covid-19. Em contrapartida registramos uma queda de vendas dessa medicação no ano de 2021, devido a vacinação no Brasil e realização de estudos que, ressaltam que em nenhum deles foi comprovada a ação in vivo da medicação. Considerações Finais: Cabe ao farmacêutico, o último elo entre a medicação e o paciente, orientar e prevenir sobre o uso indiscriminado de ivermectina, uma vez que há dados suficientes para abandonar o uso dessas medicações, por provas contundentes de que não ajudam no tratamento.Research, Society and Development2021-09-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1978710.33448/rsd-v10i11.19787Research, Society and Development; Vol. 10 No. 11; e312101119787Research, Society and Development; Vol. 10 Núm. 11; e312101119787Research, Society and Development; v. 10 n. 11; e3121011197872525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/19787/17561Copyright (c) 2021 Elismar dos Santos Souza; Weslayny Pereira Martins; Yolanda de Jesus Moraishttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSouza, Elismar dos Santos Martins, Weslayny PereiraMorais, Yolanda de Jesus 2021-10-23T19:01:11Zoai:ojs.pkp.sfu.ca:article/19787Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:39:36.923319Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study Intervención farmacéutica en el uso indiscriminado de ivermectina: un estudio comparativo Intervenção farmacêutica no uso indiscriminado da ivermectina: um estudo comparativo |
title |
Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study |
spellingShingle |
Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study Souza, Elismar dos Santos Ivermectina Farmacêutico Covid-19. Ivermectina Farmacéutica Covid-19. Ivermectin Pharmaceutical Covid-19. Souza, Elismar dos Santos Ivermectina Farmacêutico Covid-19. Ivermectina Farmacéutica Covid-19. Ivermectin Pharmaceutical Covid-19. |
title_short |
Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study |
title_full |
Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study |
title_fullStr |
Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study |
title_full_unstemmed |
Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study |
title_sort |
Pharmaceutical intervention in the indiscriminate use of ivermectin: a comparative study |
author |
Souza, Elismar dos Santos |
author_facet |
Souza, Elismar dos Santos Souza, Elismar dos Santos Martins, Weslayny Pereira Morais, Yolanda de Jesus Martins, Weslayny Pereira Morais, Yolanda de Jesus |
author_role |
author |
author2 |
Martins, Weslayny Pereira Morais, Yolanda de Jesus |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Souza, Elismar dos Santos Martins, Weslayny Pereira Morais, Yolanda de Jesus |
dc.subject.por.fl_str_mv |
Ivermectina Farmacêutico Covid-19. Ivermectina Farmacéutica Covid-19. Ivermectin Pharmaceutical Covid-19. |
topic |
Ivermectina Farmacêutico Covid-19. Ivermectina Farmacéutica Covid-19. Ivermectin Pharmaceutical Covid-19. |
description |
Introduction: The whole world is still experiencing a health emergency caused by the pandemic of the new SARS-Cov-2 coronavirus, recently, ivermectin, previously shown to have broad-spectrum antiviral activity in vitro, has been shown to be an inhibitor of the SARS-CoV-2 virus , in this scenario, the article aims to analyze the pharmaceutical performance in drugstores, and compare the pattern of consumption of the drug Ivermectin in the period of the Covid-19 pandemic in the city of Redenção-PA. Methods: An exploratory, retrospective descriptive study was carried out, with the methodological documental procedure in the evaluation of sales records of 05 (five) drugstores in the city of Redenção-PA on the indiscriminate use of ivermectin during the pandemic. The study was carried out by reviewing the sales reports issued in 3 (three) months, namely: March/April/May 2019/2020/2021, respectively. Results and discussion: During the study, a jump in the consumption of ivermectin was observed in 2020, due to the intense search for curative or preventive measures by Covid-19. On the other hand, we recorded a drop in sales of this medication in 2021, due to vaccination in Brazil and the performance of studies that highlight that in none of them the in vivo action of the medication was proven. Final Considerations: It is up to the pharmacist, the last link between the medication and the patient, to guide and prevent the indiscriminate use of ivermectin, since there is enough data to abandon the use of these medications, due to overwhelming evidence that they do not help in the treatment. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09-02 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19787 10.33448/rsd-v10i11.19787 |
url |
https://rsdjournal.org/index.php/rsd/article/view/19787 |
identifier_str_mv |
10.33448/rsd-v10i11.19787 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19787/17561 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Elismar dos Santos Souza; Weslayny Pereira Martins; Yolanda de Jesus Morais https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Elismar dos Santos Souza; Weslayny Pereira Martins; Yolanda de Jesus Morais https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 11; e312101119787 Research, Society and Development; Vol. 10 Núm. 11; e312101119787 Research, Society and Development; v. 10 n. 11; e312101119787 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1822178548659519488 |
dc.identifier.doi.none.fl_str_mv |
10.33448/rsd-v10i11.19787 |